跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PMSC-ESOMEPRAZOLE DR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PMSC-ESOMEPRAZOLE DR
Authorized
STANDARD
PMSC-ESOMEPRAZOLE DR
Pharmascience Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d799c3d0a28d08d0
Company
Pharmascience Inc
Type
Standard
Approval Details
Approval Id
d799c3d0a28d08d0
Drug Approval Canada Name
PMSC-ESOMEPRAZOLE DR
Product Name
PMSC-ESOMEPRAZOLE DR
Status
Marketed
Status Date
2023-03-06
Original Market Date
2023-03-06
Din
02528487
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC05 ESOMEPRAZOLE
Atc Name
a 02 bc 05
Aig Number
0145162002
Company Name
Pharmascience Inc
Company Address
100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path
/organization/pharmascience-inc
Company Information
Pharmaceutical Company Name
Pharmascience Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
6111 av Royalmount bureau 100
Active Ingredients
ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM DIHYDRATE)
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d799c3d0a28d08d0
Type
Standard
Back to Health Canada Approvals